Epigenetic Targets in Drug DiscoveryISBN: 978-3-527-32355-5
Hardcover
314 pages
August 2009
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability.  |
Fueled by the expertise of a team of international specialist authors, this first reference on the booming topic covers everything a drug researcher needs to know about targeting epigenetic mechanisms of disease.
The first part of the book surveys current methodologies for finding and validating drug candidates that act via epigenetic mechanisms. The second part systematically surveys known and suspected drug targets within the epigenetic machinery, including the discovery and development of vorinostat, the first marketed epigenetic drug.
The first part of the book surveys current methodologies for finding and validating drug candidates that act via epigenetic mechanisms. The second part systematically surveys known and suspected drug targets within the epigenetic machinery, including the discovery and development of vorinostat, the first marketed epigenetic drug.
Buy Both and Save 25%!
+
Epigenetic Targets in Drug Discovery (US $210.00)
-and- Protein-Ligand Interactions (US $185.00)
Total List Price: US $395.00
Discounted Price: US $296.25 (Save: US $98.75)
